Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI14-191

A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy with Ginseng for Patients on Treatment with Regorafenib: HCRN GI14-191.

Status: Closed to Accrual

This is a randomized, multi-center phase II study of ginseng in colorectal cancer patients treated with regorafenib to determine if ginseng will reduce fatigue in this patient population and improve adherence to regorafenib. Ninety (90) subjects will be enrolled and randomized using a 2:1 allocation, with 60 subjects enrolled in the regorafenib + ginseng group and 30 enrolled in the regorafenib + no ginseng group.

  • Condition:
    • Colorectal Cancer
    • Palliative Medicine
    • Supportive Care
  • Intervention:
    • Drug: Regorafenib
    • Dietary Supplement: Ginseng
  • Phase: Phase 2

For full description, see www.clinicaltrials.gov.

Read a news release about this trial.

Project Manager: Donna Sullivan, dsullivan@hoosiercancer.org; (317) 634-5842, ext. 40.